Energy News  
EPIDEMICS
Zimbabwe lacks AIDS drugs to expand treatment: official

by Staff Writers
Harare (AFP) July 11, 2010
Zimbabwe may not have enough anti-AIDS drugs to comply with World Health Organisation recommendations on providing treatment to people with HIV, a top health official said Sunday.

Zimbabwe is currently treating about 200,000 people whose immune systems have been severely weakened by the disease, but the WHO recommends that treatment should start earlier.

"The number of people in need of treatment will double if we follow the World Health Organisation plan," Tsitsi Mutasa Apollo, co-ordinator of HIV treatment in the health ministry, said in the state-run Sunday Mail.

"We are likely to experience more drug shortages," said Apollo.

The new guidelines would mean about 500,000 people need treatment, the paper said.

Zimbabwe's prevention and treatment campaign relies on donor funding, after a near decade of economic crisis also which crippled health services.

The country imposes an AIDS levy on workers to fund drug procurement for over 1.6 million people living with the virus.

Last year HIV infected 13.7 percent of adults, down from a high of 33 percent in 1999.

The decline has been attributed to donor-backed prevention campaigns which promotes safe sex and discourages multiple sexual partners.



Share This Article With Planet Earth
del.icio.usdel.icio.us DiggDigg RedditReddit
YahooMyWebYahooMyWeb GoogleGoogle FacebookFacebook



Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola



Memory Foam Mattress Review
Newsletters :: SpaceDaily :: SpaceWar :: TerraDaily :: Energy Daily
XML Feeds :: Space News :: Earth News :: War News :: Solar Energy News


EPIDEMICS
Breakthrough antibodies neutralize most known AIDS strains
Washington (AFP) July 8, 2010
US researchers have discovered two powerful antibodies that neutralize more than 90 percent of all known strains of the HIV virus in the lab, new research released Thursday showed. NIH-led scientists discovered the antibodies known as VRCO1 and VRCO2 that prevent most HIV strains from infecting human cells. The find is a potential breakthrough for advancing HIV vaccine design, and antibody t ... read more







EPIDEMICS
National Clean Fuels Angling To Be Major Player In G-20 Carbon Market

New System To Reduce Heating Costs In Cold Climates

Hydro, Wave, And Tidal Power Market Outlook Bright

EU investigating Electrabel over dominant position

EPIDEMICS
Obama loses drilling moratorium appeal

A few patches of tar empty Biloxi's white sand beaches

Oil companies reeling from drilling moratorium uncertainty

BP 'pleased' with progress of oil fix mission

EPIDEMICS
Study Shows Stability And Utility Of Floating Wind Turbines

Leading French Wind Farm Developer Says Yes To Triton

Floating ocean wind turbines proposed

China to dominate wind power

EPIDEMICS
Pennsylvania Invests 18 Million Dollars To Support Alternative Energy Projects

Understanding Solar PV Cost And Financing Estimators

Abound Solar Receieves Conditional Commitment For Loan Guarantee By US DoE

Third In Series Of Italian Solar Power Plants Now Operational

EPIDEMICS
Nuclear Power Market Outlook For Developing Countries

Canadian medical reactor gets nod to restart

Areva negotiating two more EPR reactors with China: CEO

'Atomic Anne' Lauvergeon stays in power at Areva: source

EPIDEMICS
Philippines gets funding for green energy

New Biofuels Processing Method For Mobile Facilities

Energy Crops Growing On Seawater

New Ethanol Fact Book Highlights Benefits Of U.S. Ethanol Program

EPIDEMICS
China Sends Research Satellite Into Space

China eyes Argentina for space antenna

Seven More For Shenzhou

China Signs Up First Female Astronauts

EPIDEMICS
Researchers Calculate The Cost Of Co2 Emissions, Call For Carbon Tax

Research Helps Predict Future Impact Of Climate Change

British climate change scientists cleared of dishonesty

China to host new round of climate talks in October: report


The content herein, unless otherwise known to be public domain, are Copyright 1995-2010 - SpaceDaily. AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement